Soy isoflavones reduce electronegative low-density lipoprotein (LDL -) and anti-LDL- autoantibodies in experimental atherosclerosis

European Journal of Nutrition

Volumn 46, Issue 3, 2007, Pages 125-132

  Teixeira Damasceno, Nágila Raquel ^a   Apolinário, Elaine ^b   Dias Flauzino, Fabiana ^b   Fernandes, Irene ^c   Abdalla, Dulcineia Saes Parra ^b  

^a Department of Epidemiology School of Public Health   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

Hypercholesterolemia; Minimally modified LDL; Oxidized LDL

Indexed keywords

ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTRON TRANSPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PLASMA; RABBIT; SOYBEAN;

ANIMALS; AORTA; ATHEROSCLEROSIS; AUTOANTIBODIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; ISOFLAVONES; MALE; RABBITS; SOYBEANS;

ANIMALIA; GLYCINE MAX; ORYCTOLAGUS CUNICULUS;

EID: 33947611205     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-006-0640-9     Document Type: Article

References (54)

1. Davies J, Rudd J, Weisberg P (2004) Molecular and metabolic imaging of atherosclerosis. J Nuclear Med 45(11):1898-1907
2. Ramaa C, Shirode A, Mundada A, Kadam V (2006) Nutraceuticals - an emerging era in the treatment and prevention of cardiovascular diseases. Curr Pharm Biotechnol 7(1):15-23
3. Zhan S, Ho S (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397-408
4. Arteaga E, Villaseca P, Rojas A, Marshall G, Bianchi M (2004) Phytoestrogen possess a weak antioxidant activity on low density lipoprotein in contrast to the flavonoid quercetin in vitro in postmenopausal women. Climateric 7(4):397-403
5. Clarkson T (2002) Soy, soy phytoestrogens and cardiovascular disease. J Nutr 132:566S-569S
6. Weggemans R, Trautwein E (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in human: a meta-analysis. Euro J Clin Nut 57:940-946
7. Mitchell J,Gardner P, McPhail D, Morrice P, Collins A, Duthie G (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model system. Arch Biochem Biophys 360:142-148
8. Lee C, Kwon S, Na S, Lim S, Lee J (2004) Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits. J Korean Med Sci 19:656-661
9. Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, Fitzpatrick LA (2006) Intimal estrogen receptor ER(b), but nor ERa expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab 91:2718-2720
10. Setchell K (1998) Phytoestrogens: The biochemistry, physiology and implications for human health of soy isoflavones. Am J Clin Nutr 68(6):1333-1346
11. Anthony M, Clarkson T, Bullock B, Wagner J (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17:2524-2531
12. Patel R, Boersman B, Crawfor J, Hogg N, Kirk M, Kalyanamara B, Parks D, Barnes S, Darley-Usmar V (2001) Antioxidant mechanisms of isoflavones in lipid system: Paradoxical effects of peroxyl radical. Free Radic Biol Med 31:1570-1581
13. Kerry N, Abbey M (1998) The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis 140(2):341-347
14. Turner R, Baron T, Wolffram S, Minihane A, Cassidy A, Rimbach G, Weinberg P (2004) Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic Res 38(2):209-216
15. Tinahones F, Gómez-Zumaquero J, Garrido-Sánchez L, García-Fuentes E, Rojo-Martínez G, Esteva I, Adana M, Cardona F, Soriguer F (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46:452-457
16. Ziouzenkova O, Sevanian A (2000) Oxidative modification of low density lipoprotein (LDL) in HD patients: role in electronegative LDL formation. Blood Purif 18(3):169-176
17. Sánchez-Quesada J, Benítez S, Ordóñez-Llanos J (2004) Electronagative low density lipoprotein. Curr Opin Lipidol 15:329-335
18. Sevanian A, Asatryan L, Ziouzenkova O (1999) Low density lipoprotein (LDL) modification: basic concepts and relationship to atherosclerosis. Blood Purif 17:66-78
19. Association of Official Analytical Chemistry: Official methods of analysis ed 13 Washington, AOAC, 1980
20. Franke A, Custer l, Tanaka Y (1998) Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 68:1466-1473
21. Coward L, Barnes N, Setchell K, Barnes S (1993) Genistein, daidzein and their β-glycoside conjugates: antimour isoflavones in soybean foods from american and asian diets. J Agric Food Chem 41:1961-1967
22. Wang H, Murphy P (1996) Mass balance study of isoflavones during soybean processing. J Agric Food Chem 44:2377-2383
23. Setchell K, Welsh M, Lim C (1987) HPLC analysis of phytoestrogens in soy protein preparation with ultraviolet, electrochemical and thermospray mass spectrometric detection. J Chromatogr 385:267-274
24. Damasceno N, Rodrigues F, Gidlund M, Goto H, Dias C, Abdalla D (2001) Casein and soy protein isolate in experimental atherosclerosis: Influence on hypercholesterolemia and lipoprotein oxidation. Ann Nutr Metab 45:38-46
25. Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193(1):265-275
26. Damasceno N, Sevanian A, Apolinário E, Oliveira J, Fernandes I, Abdalla D (2006) Detection of electronegative low density lipoprotein (LDL)) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clinical Biochemistry 39:28-38
27. Barros M, Bertolami M, Abdalla D, Ferreira W (2006) Identification of mildly oxidized low density lipoprotein (electronegative LDL) and its autoantibodies IgG in children and adolescents hypercholesterolemic offsprings. Atherosclerosis 184(1):103-107
28. Yla-Herttuala S, Jaakkola O, Ehnholm C, Tikkanem M, Solakivi T, Sarkioja T, Nikkari T (1988) Characterization of two lipoproteins containing apolipoprotein B and E from lesion-free human aortic intima. J Lipid Res 29:563-572
29. Owens G, Burgoon M, Devlin M, Gilden D (1997) Extraction and purification of active IgG from SSPE and MS brain. J Virol Methods 68:119-125
30. Kawakami Y, Tsurugasaki W, Nakamura S, Osada K (2005) Comparison of regulative functions between dietary soy isoflavones aglycone and glucoside on lipid metabolism in rats fed cholesterol. J Nutr Biochem 16:205-212
31. Song T, Lee S-O, Murphy P, Hendrich S (2003) Soy protein with or without isoflavones, soy germ extract, and daidzein lessen plasma cholesterol level in golden Syrian hamsters. Exp Biol Med 228:1063-1068
32. Geaves K, Parks J, Williams J, Wagner J (1999) Intact dietary sou protein, but not adding an isoflavones-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr 129:1585-1592
33. Wang Y, Jones P, Ausman L, Lichtenstein A (2001) Soy protein reduces triglycerides levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis 173(2):269-275
34. Anderson J, Johnstone B, Cook-Newell M (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282
35. Mezei O, Chou C, Kennedy K, Tovar-Palacio C, Shay N (2002) Hepatic cytochrome p450-2A and phosphoribosylpyrophosphate synthetase associated protein mRNA are induced in gerbils after consumption of isoflavone-containing protein. J Nutr 132:2538-2544
36. Nogowski L, Mackowiak P, Kandulska K, Szkudelski T, Nowak K (1998) Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab 42:360-366
37. Baum J, Teng H, Erdman J (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68:545-551
38. Jenkins D, Kendall C, Garsetti M, et al. (2000) Effect of soy protein on low density lipoprotein oxidation and ex vivo sex hormone receptor activity - a controlled crossover trial. Metabolism 49:537-43
39. Wiseman H, O'Reilly J, Adlercreutz H, Mallet A, Bowey E, Rowland I, Sanders T (2000) Isoflavones Phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low density lipoprotein to oxidation in humans. Am J Clin Nutr 72:395-400
40. Samman S, Wall P, Chan G, Smith S, Petocz P (1999) The effect of supplementation with isoflavones on plasma lipids and oxidizability of low density lipoprotein in premenopausal women. Atherosclerosis 147:277-283
41. Eldrigde A (1982) High performance liquid chromatography separation of soybean isoflavones and their glucosides. J Chromatography 234:494-496
42. Wang H, Murphy P (1994) Isoflavones content in commercial soybean foods. J Agric Food Chem 44:2377-2383
43. Subbiah M, Sprinkle J, Rymaszewski Z, Yunker R (1989) Short-term exposure to high dietary cholesterol in early life: arterial changes and response after normalization of plasma cholesterol. Am J Clin Nutr 50:68-72
44. Shaw P, Binder C, Chang M, Hartvigsen K, Horkko S, Miller Y, Woelkers D, Corr M, Witztum J (2005) The role of natural antibodies in atherogenesis. J Lipid Res 46(7):1353-1363
45. Shaw P (2004) Rethinking oxidized low density lipoprotein, its role in atherosclerosis and the immune response associated with it. Arch Immunol Ther Exp 52:225-239
46. Binder C, Shaw P, Chang M, Booullier A, Hartvigsen K, Hörkkö S, Miller Y, Woelkers D, Corr M, Witztum J (2005) The role natural antibodies in atheroclerosis. J Lipid Research 46:1353-1363
47. Binder C, Silverman G (2005) Natural antibodies and the immunity of atherosclerosis. Springer Semin Immun 26:385-404
48. Tertov V, Sobenin I, Orekhov A, Jaakkola O, Solakivi T, Nnikkari T (1996) Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis 122(2):191-199
49. Wagner J, Cefal W, Anthony M, Litwak K, Zhang L, Clarkson T (1997) Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesterol ester content in ovariectomized cynomolgus monkeys. Metabolism 46(6): 698-705
50. Jenkins D, Kedall C, Garsetti M, Rosenberg-Zang R, Jackson C, Agarwal S, Diamandi E, Parkert R, Faulkner D, Vuksan V, Vidgen E (2000) Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity - a controlled crossover trial. Metabolism 49(4):537-546
51. Wu J, Wang X, Chiba H, Higuchi M, Nakatani T, Ezaki O, Cui H, Yamada K, Ishimi Y (2004) Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism 53(7):942-948
52. Manzoni MS, Rossi EA, Carlos IZ, Vendramini RC, Duarte AC, Damaso AR (2005) Fermented soy product supplemented with isoflavones affected fat depots in juvenile rats. Nutrition 21(10):1018-1024
53. Hertrampf T, Degen GH, Kaid AA, Laudenbach-Leschowsky U, Seibel J, Di Virgilio AL, Diel P (2006) Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Medica 72(6):484-487
54. Weickert MO, Reimann M, Otto B, Hall WL, Vafeiadou K, Hallund J, Ferrari M, Talbot D, Branca F, Bugel S, Williams CM, Zunft HJ, Koebnick C (2006) Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J Negat Results Biomed 5:11-14